USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ARDANE THERAPEUTICS
Address:
1 Davol Square
Suite 200
PROVIDENCE, RI 02903-
Phone:
N/A
URL:
N/A
EIN:
127053038
DUNS:
831336883
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $352,596.00 1

Award List:

Treatment of stroke using a novel PDZ binding peptidomimetic drug.

Award Year / Program / Phase:
2011 / SBIR / Phase I
Award Amount:
$352,596.00
Agency:
HHS
Principal Investigator:
Elizabeth Garcia – 401-863-1429
Abstract:
DESCRIPTION (provided by applicant): Abstract Stroke is the third leading pathological cause of death, behind heart and cancer (NCHS mortality data.). We are developing a new drug, CN 2097, that has demonstrated therapeutic potential for stroke. CN 2097 obstructs the propagation of the cell… More